Doctors noted their dissatisfaction with a direct mail marketing arrangement between Eli Lilly and CVS Caremark in an Indianapolis Star report.
The consternation relates to direct mail communications that are “designed to look like an important letter for a treatment for my patients, not what it really was — a paid promotion by a drug maker,” Dr. Daniel Carlat, a Massachusetts psychiatrist identified in the article as a “well-known critic of drug marketing,” told the Star.
At issue as well: the appropriateness of the relationship between drug manufacturer Lilly and pharmacy CVS Caremark.
